Ex vivo RLC phosphorylation partially rescues detrimental functional effects of the D166V hypertrophic cardiomyopathy mutation in mouse cardiac muscle, though it unexpectedly decreases maximal tension.
No takes yet. Share an insight, caveat, or question.
May partially rescue HCM mutation effects in mouse models; leaves open clinical translation due to tension reduction.
Muthu et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: